Comparative Analysis of Clinical Trial Outcomes between African American and White Patients Treated with Lenalidomide and Dexamethasone for Multiple Myeloma (MM)
Ailawadhi, Sikander, Larkins, Gail, Chung, Weiyuan, Srinivasan, Shankar, Agarwal, Amit
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib
Richardson, Paul G., Siegel, David, Baz, Rachid, Kelley, Susan L., Munshi, Nikhil C., Laubach, Jacob, Sullivan, Daniel, Alsina, Melissa, Schlossman, Robert, Ghobrial, Irene M., Doss, Deborah, Loughney, Nora, McBride, Laura, Bilotti, Elizabeth, Anand, Palka, Nardelli, Lisa, Wear, Sandra, Larkins, Gail, Chen, Min, Zaki, Mohamad H., Jacques, Christian, Anderson, Kenneth C.
Published in Blood (14.03.2013)
Published in Blood (14.03.2013)
Get full text
Journal Article
Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM)
Ailawadhi, Sikander, McCarthy, Philip L., Holstein, Sarah A., Larkins, Gail, Chung, Weiyuan, Srinivasan, Shankar, Agarwal, Amit, Lonial, Sagar
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Recognition of early mortality in multiple myeloma by a prediction matrix
Terebelo, Howard, Srinivasan, Shankar, Narang, Mohit, Abonour, Rafat, Gasparetto, Cristina, Toomey, Kathleen, Hardin, James W., Larkins, Gail, Kitali, Amani, Rifkin, Robert M., Shah, Jatin J.
Published in American journal of hematology (01.09.2017)
Published in American journal of hematology (01.09.2017)
Get full text
Journal Article
Development of a Predictive Model of Multiple Myeloma (MM) Patient (pt) Outcomes Based on Treatment Class Transitions Using the Connect® MMpatient Registry
Jagannath, Sundar, Rifkin, Robert M., Gasparetto, Cristina J., Toomey, Kathleen, Durie, Brian G.M., Hardin, James W., Terebelo, Howard R., Wagner, Lynne, Narang, Mohit, Srinivasan, Shankar, YoussefAgha, Ahmed, Kitali, Amani, Larkins, Gail, Agarwal, Amit, Abonour, Rafat
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Strategies associated with enhanced inclusion of racial and ethnic minorities in clinical cancer research: US Centers of Excellence current practices
Regnante, Jeanne, Richie, Nicole, Fashoyin-Aje, Lola, Hall, Laura Lee, Clark, Luther, Dang, Julie, Esnaola, Nestor F., Ford, Marvella Elizabeth, Gonzalez, Evelyn, Highsmith, Quita, Hoover, Spencer C., Larkins, Gail, Lee, Simon Craddock, Louis, J’Aimee, McNeill, Lorna H, Petereit, Daniel, Vichnin, Michelle, Williams, Erin Fenske, Obasaju, Coleman K.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Clinical Outcomes of Patients with Newly Diagnosed Multiple Myeloma Receiving Triplet Therapy in the Connect MM® Disease Registry
Shah, Jatin J., Abonour, Rafat, Narang, Mohit, Mehta, Jayesh, Terebelo, Howard R., Gasparetto, Cristina J, Toomey, Kathleen, Hardin, James W, Srinivasan, Shankar, Larkins, Gail, Nagarwala, Yasir, Rifkin, Robert M.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Overall survival in newly diagnosed MM patients with del(17p): A report from the Connect MM Registry
Shah, Jatin J., Abonour, Rafat, Durie, Brian G., Mehta, Jayesh, Narang, Mohit, Terebelo, Howard R., Gasparetto, Cristina, Toomey, Kathleen, Hardin, James W., Srinivasan, Shankar, Larkins, Gail, Ricafort, Rosanna J., Nagarwala, Yasir M., Rifkin, Robert M.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Characteristics and survival of African American (AA) newly diagnosed multiple myeloma (NDMM) patients (Pts): A report from the Connect MM Registry
Toomey, Kathleen, Gasparetto, Cristina, Shah, Jatin J., Abonour, Rafat, Mehta, Jayesh, Narang, Mohit, Terebelo, Howard R., Hardin, James W., Srinivasan, Shankar, Larkins, Gail, Ricafort, Rosanna J., Nagarwala, Yasir M., Rifkin, Robert M.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
MM-014: A phase 2 trial evaluating efficacy, safety, and biomarkers of pomalidomide plus low-dose dexamethasone (POM + LoDEX) in relapsed/refractory multiple myeloma (RRMM) following second-line lenalidomide plus dexamethasone (LEN + DEX)
Siegel, David Samuel DiCapua, Agajanian, Richy, Gaur, Rakesh, Karamlou, Kasra, Kaya, Hakan, Sturniolo, Michael, Ricafort, Rosanna J., Larkins, Gail, Srinivasan, Shankar, Chopra, Rajesh, Thakurta, Anjan, Nagarwala, Yasir M., Kruter, Flavio
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Pomalidomide (POM) with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Outcomes Based on Prior Treatment Exposure
Vij, Ravi, Hofmeister, Craig C., Richardson, Paul G., Jagannath, Sundar, Siegel, David S., Baz, Rachid, Chen, Min, Zaki, Mohamed, Larkins, Gail, Anderson, Kenneth C.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Treatment Outcomes with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDex) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) and Del(17p13) and/or t(4;14)(p16;q32) Cytogenetic Abnormalities Who Have Received Prior Therapy with Lenalidomide (LEN) and Bortezomib (BORT)
Richardson, Paul G., Jakubowiak, Andrzej, Bahlis, Nizar J., Siegel, David S., Chen, Christine I., Chen, Min, Zaki, Mohamed, Larkins, Gail, Anderson, Kenneth C.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Pomalidomide (POM) with or without low-dose dexamethasone (LoDEX) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Outcomes in pts refractory to lenalidomide (LEN) and/or bortezomib (BORT)
Vij, Ravi, Richardson, Paul Gerard Guy, Jagannath, Sundar, Siegel, David Samuel DiCapua, Baz, Rachid C., Srinivasan, Shankar, Larkins, Gail, Zaki, Mohamed H., Hussein, Mohamad A., Anderson, Kenneth Carl
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Randomized, Open Label Phase 1/2 Study of Pomalidomide (POM) Alone or in Combination with Low-Dose Dexamethasone (LoDex) in Patients (Pts) with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide (LEN) and Bortezomib (BORT): Phase 2 Results
Richardson, Paul G., Siegel, David S., Vij, Ravi, Hofmeister, Craig C., Jagannath, Sundar, Chen, Christine, Lonial, Sagar, Jakubowiak, Andrzej J, Bahlis, Nizar J, Baz, Rachid, Larkins, Gail, Chen, Min, Zaki, Mohamed, Anderson, Kenneth C.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or In Combination with Low-Dose Dexamethasone In Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib
Richardson, Paul G, Siegel, David, Baz, Rachid, Kelley, Susan L., Munshi, Nikhil C., Sullivan, Daniel, Alsina, Melissa, Doss, Deborah, McBride, Laura, Larkins, Gail, Lizza, Maria, Yu, Xin, Zaki, Mohamed, Jacques, Christian J., Anderson, Kenneth C.
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
A Phase 1/2 Multi-Center, Randomized, Open Label Dose Escalation Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of Pomalidomide Alone or in Combination with Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide and Bortezomib
Richardson, Paul, Siegel, David, Baz, Rachid, Kelley, Susan L., Munshi, Nikhil C., Sullivan, Daniel, McBride, Laura, Doss, Deborah, Larkins, Gail, Jacques, Christian, Donaldson, Arlene, Anderson, Kenneth C.
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article